If you have locally advanced or metastatic NSCLC and have received at least one chemotherapy regimen that has not worked, you may be a candidate for Tarceva. Speak with your doctor about whether Tarceva is right for you.

All drugs have the possibility of causing some side effects. Some rare, but possibly serious, side effects may occur with Tarceva. In large clinical studies, there were infrequent reports of a lung injury known as Interstitial Lung Disease (ILD) and have included fatalities. Tarceva may cause liver problems. Let your doctor know if you have a history of liver disease. Women should also avoid becoming pregnant or breastfeeding while taking Tarceva.

Tarceva is a pill taken by mouth once a day to treat your cancer. Tarceva is used for patients with advanced NSCLC who have received at least one previous chemotherapy regimen that did not work. Take Tarceva at least one hour before or two hours after eating.

Tarceva is an FDA-approved targeted cancer therapy clinically proven to help some NSCLC patients live significantly longer. In addition to improving survival, Tarceva may slow or stop the growth of cancer - and may even shrink the tumors in some patients. Tarceva is convenient to take; it's a pill you take by mouth once a day as prescribed by your doctor. Individual results may vary. Though individual results may vary, Tarceva has been shown to help some patients live longer.

Tarceva monotherapy is indicated for the treatment of patients with locally advanced or metastatic Non-Small Cell Lung Cancer (NSCLC) after failure of at least one prior chemotherapy regimen. Results from two multicenter, placebo-controlled, randomized, Phase III trials conducted in first-line patients with locally advanced or metastatic NSCLC showed no clinical benefit with the concurrent administration of Tarceva with platinum-based chemotherapy, and its use is not recommended in that setting.

Since food substantially increases the bioavailability of erlotinib and may increase the risk of adverse events, patients should be instructed to take Tarceva at least one hour before or two hours after the ingestion of food. The degree that food increases the bioavailability of erlotinib may vary; therefore, Tarceva tablets should be taken on an empty stomach to help ensure that patients obtain consistent plasma levels of the drug.

Only your urologist can determine if you are a candidate, based upon your history & physical examination, as well as his clinical judgment. Karatas OF, Tasci A, Tugcu V. Erectile functions in BPH patients after photoselective vaporisation of the prostate laser surgery. Eur Urol 2006;5(2 suppl.):272 abstract 997. EAU Meeting, Apr 5-8,2006 Paris, France. Malek RS, Kuntzman RS, Barrett DM. High power potassium-titanyl-phosphate laser vaporization prostatectomy. J Urol. 2000 Jun;163(6):1730-3.

Urinary frequency or other bladder symptoms caused by compression of the bladder by fibroids or compression of the ureters, which can cause hydronephrosis.

Candidates for this surgery are generally younger, more active patients. The partial knee replacement allows for symptoms of pain or discomfort. The procedure allows younger patients to buy time before they need a full knee replacement. The procedure is also effective for older patients if they have disease localized to one half of the joint.

If you have previously had a heart attack or have coronary artery disease and are experiencing shortness of breath during physical activity, feeling tired or weak, and having difficulty performing everyday activities you may be a candidate for SVR Surgical Ventricular Restoration. Ask your doctor for more information.

Only Dr. Shaw can determine if you are a candidate, based upon your history & physical examination, as well as his clinical judgment.

If you are starting to thin, balding, or completely bald, you are a candidate for hair transplant surgery. Those who have been losing hair for a few years at a moderate to dramatic rate should consider hair transplant, as it is the only permanent solution to hair loss.

Drs. Jenkins and Omphroy performed the first laser refractive surgeries in the islands and have continued to stay in the forefront of the technology curve. They are trained in all these procedures using the most advanced equipment available in Hawaii and will select what is appropriate for each patient. To explore your options, please contact us or take our online quiz.

A comprehensive eye examination with dilation of the pupils will provide enough information to determine if you could be considered for a second opinion consult.Dr. Kohansby performs all the necessary testing as part of a comprehensive eye examination.

To be eligible for refractive surgery, your eye must be in good health and your vision must be stable. The minimum age for refractive surgery is 18. Since some people are better candidates than others, a consultation at The Refractive Institute is essential. You'll undergo a series of tests and measurements that will determine if refractive surgery is right for you.

A good LASIK candidate must have healthy eyes (no glaucoma, infections, cataracts, severe dry eye, or other condition that would impact healing), must be at least 18 for some procedures and at least 21 for others, and since vision must be stable for at least a year before surgery, often good candidates are often in their mid-twenties before their eyes stabilize.

Most men in good general health are candidates for hair transplantation. In order to determine your candidacy, you should arrange to have a free, private consultation with a NHI physician. During your consultation, the physician will measure your donor density and scalp laxity. He will also determine your balding pattern and take your individual hair characteristics such as color and wave into consideration to develop a plan for your hair restoration.

If you are in good health and have hanging abdominal skin or a fat deposit that is large and doesn't go away with exercise and eating right then you may be a good person for getting a tummy tuck. Some women after being pregnant or after gaining a large amount of weight will predominantly have an advantage from getting the operation.

Tarceva is a targeted cancer treatment. Unlike many traditional chemotherapies, Tarceva affects certain cancer cell activities. Tarceva is designed to block tumor cell growth by targeting the protein in your body called the Human Epidermal Growth Factor Receptor 1 (HER1/EGFR). This protein is important for tumor cell growth in NSCLC.

Tarceva is approved as monotherapy, meaning it is used without chemotherapy, for second- and third-line treatment of advanced NSCLC patients. This means that your doctor can prescribe Tarceva after one chemotherapy regimen has not worked.

Rash and diarrhea were the most common side effects associated with Tarceva. They were generally mild to moderate. In large clinical studies, severe rash occurred in 9% of patients and severe diarrhea occurred in 6% of patients. You may also have other changes in your skin.

A rash may appear on your skin within 8-10 days of starting Tarceva therapy, most likely on your upper body or head. It may look like acne or dry skin, but it is not acne. Avoid acne-related treatments, including products with benzoyl peroxide. Rash is a common reaction to Tarceva. If you get a rash, do not stop taking Tarceva unless your doctor instructs you to do so. Try using a mild soap to wash areas affected by the rash, moisturize the area with a mild lotion and avoid sun exposure.

Patients will need to speak with their insurance provider to determine if Tarceva is covered. Each provider will respond differently. However, Medicare supplemental drug plans do provide coverage for Tarceva for advanced non-small cell lung cancer.